Medicus Pharma up 9% in Pre-market Trading as FDA Approves Anti-cancer Patch for Horses

MT NewswiresDec 12 08:18 ET

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation From the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

newsfileDec 12 07:30 ET

Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region

newsfileDec 2 07:30 ET

Medicus Pharma Ltd. Expands With Strategic Takeover

TipRanksNov 25 08:30 ET

Leadership Changes at Medicus Pharma Ltd

TipRanksNov 18 08:10 ET

Press Release: Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

Dow JonesNov 18 07:30 ET